Back to Markets

GILD vs TMO

A side-by-side look at GILD and TMO, updated throughout the trading session.

Performance, normalized

Z-scored closes: both paths on one scale, price levels aside.

Loading history…
Live figures are refreshing. Check back in a moment.

GILD vs TMO: how they differ

Gilead Sciences, Inc. (GILD) and Thermo Fisher Scientific Inc. (TMO) are both in the Healthcare sector: GILD is classified in Drug Manufacturers - General, TMO in Medical - Diagnostics & Research. GILD trades on NASDAQ and TMO on NYSE.

GILD trades about 6.8 million shares a day on average, against 2.1 million for TMO. TMO has the higher beta (0.88 against 0.33 for GILD), meaning it has historically moved more with the broad market. Over the trailing twelve months, GILD paid $3.25 per share in dividends and TMO paid $1.84 per share.

Figures as of October 14, 2026.

The chart Z-score-normalizes each closing series, computing (close − mean) ÷ standard deviation over the window, so both paths share one scale regardless of price level, and correlation is computed on daily returns. Figures update throughout the trading session. Nothing on this page is financial advice.